Matches in Wikidata for { <http://www.wikidata.org/entity/Q91207941> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q91207941 description "article scientifique publié en 2019" @default.
- Q91207941 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91207941 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91207941 description "scientific article published on 09 November 2019" @default.
- Q91207941 description "wetenschappelijk artikel" @default.
- Q91207941 description "наукова стаття, опублікована 9 листопада 2019" @default.
- Q91207941 name "Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-20" @default.
- Q91207941 name "Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-20" @default.
- Q91207941 type Item @default.
- Q91207941 label "Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-20" @default.
- Q91207941 label "Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-20" @default.
- Q91207941 prefLabel "Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-20" @default.
- Q91207941 prefLabel "Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-20" @default.
- Q91207941 P1433 Q91207941-5B1998F2-D996-464D-8846-3FF17CA0A2D9 @default.
- Q91207941 P1476 Q91207941-A81B1D31-19C4-4CC7-A7A6-EF6D3C52E48E @default.
- Q91207941 P2093 Q91207941-427DAA25-972C-45F2-83A7-5CF2AB037FBD @default.
- Q91207941 P2093 Q91207941-524CCB53-0EA1-4165-AC73-D1413D92F946 @default.
- Q91207941 P2093 Q91207941-7EBA98A0-D0D4-4ED7-9860-A436A8BF5434 @default.
- Q91207941 P2093 Q91207941-92B89193-8471-4554-8874-C78530B7FB8C @default.
- Q91207941 P2093 Q91207941-A207596D-81D3-4A36-950A-BB155F7AE97D @default.
- Q91207941 P2093 Q91207941-AFA12AD5-258D-4067-AA43-CD4D3F6DB231 @default.
- Q91207941 P2093 Q91207941-DD6D1BEB-9DFD-434B-8EF4-B940A9832786 @default.
- Q91207941 P2093 Q91207941-E279AD64-DD20-48CB-BE6C-1CE7CE762EF6 @default.
- Q91207941 P2093 Q91207941-E38642CF-0533-4F69-A85E-87DDE8435AC1 @default.
- Q91207941 P2093 Q91207941-E74B5C47-301F-4724-A642-5B0294B55FD0 @default.
- Q91207941 P304 Q91207941-0F14CBBC-B488-453A-9CE9-E2532455B950 @default.
- Q91207941 P31 Q91207941-92387765-6943-4DE2-961D-332AC8E31665 @default.
- Q91207941 P31 Q91207941-ed9cfb67-6718-419a-bbd5-6aeb3571f473 @default.
- Q91207941 P356 Q91207941-787489B5-CBAA-48BB-BD23-23B432941180 @default.
- Q91207941 P433 Q91207941-D54D20E0-01A9-441A-8CB1-0D34D92B587C @default.
- Q91207941 P478 Q91207941-2978DA0A-555F-45E2-9A51-AC791A99DD6A @default.
- Q91207941 P577 Q91207941-EB2FABA9-40AC-43E9-B57C-0D7D41316B9D @default.
- Q91207941 P698 Q91207941-E54DF8EA-1170-415B-BF00-769CF1B0AF3E @default.
- Q91207941 P921 Q91207941-605431A9-9B82-4C3C-BAE5-33419E41007A @default.
- Q91207941 P932 Q91207941-4A1928C5-320F-4F93-B873-7860E15F2523 @default.
- Q91207941 P356 S13052-019-0736-5 @default.
- Q91207941 P698 31706338 @default.
- Q91207941 P1433 Q15762169 @default.
- Q91207941 P1476 "Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-2017 epidemic season: a systematic review of seven Italian reports" @default.
- Q91207941 P2093 "Alberto Villani" @default.
- Q91207941 P2093 "Andrea Dotta" @default.
- Q91207941 P2093 "Andrea Wolfler" @default.
- Q91207941 P2093 "Antonio Del Vecchio" @default.
- Q91207941 P2093 "Fabio Midulla" @default.
- Q91207941 P2093 "Giovanni A Rossi" @default.
- Q91207941 P2093 "Giuliana Gualberti" @default.
- Q91207941 P2093 "Renato Cutrera" @default.
- Q91207941 P2093 "Rocco Merolla" @default.
- Q91207941 P2093 "Simonetta Picone" @default.
- Q91207941 P304 "139" @default.
- Q91207941 P31 Q13442814 @default.
- Q91207941 P31 Q7318358 @default.
- Q91207941 P356 "10.1186/S13052-019-0736-5" @default.
- Q91207941 P433 "1" @default.
- Q91207941 P478 "45" @default.
- Q91207941 P577 "2019-11-09T00:00:00Z" @default.
- Q91207941 P698 "31706338" @default.
- Q91207941 P921 Q45051448 @default.
- Q91207941 P932 "6842491" @default.